Increased Morbidity in Males Diagnosed With Gynecomastia: A Nationwide Register-based Cohort Study.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 07 12 2022
pmc-release: 31 01 2024
medline: 19 6 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

Evidence on the long-term and general health of males with gynecomastia is lacking. To assess health before and following a diagnosis of gynecomastia. A register-based cohort study of 140 574 males, of which 23 429 were diagnosed with incident gynecomastia and age- and calendar-matched (1:5) to 117 145 males without gynecomastia from the background population. Males with gynecomastia were stratified into males without (idiopathic) or with a known preexisting risk factor (disease/medication). Cox and logistic regression models investigated associations of disease risk according to International Classification of Diseases 10th revision sections following and before gynecomastia diagnosis. A total of 16 253 (69.4%) males in the cohort were identified with idiopathic gynecomastia. These males had a statistically significant higher risk of future disease across all included disease chapters (hazard ratio [HR], 1.19-1.89), with endocrine diseases representing the greatest disease risk (HR, 1.89; 95% CI, 1.76-2.03). The highest subchapter disease risk was observed for disorders of the endocrine glands (odds ratio [OR], 7.27; 95% CI, 6.19-8.54). Similarly, the ORs of comorbidities were higher across all included disease sections (OR, 1.05-1.51), except for psychiatric disease (OR, 0.72; 95% CI, 0.68-0.78), with the highest association with musculoskeletal/connective tissue (OR, 1.51; 95% CI, 1.46-1.57) and circulatory (OR, 1.36; 95% CI, 1.29-1.43) diseases. The presence of idiopathic gynecomastia is an important first clinical symptom of an underlying disease and a significant predictor of future disease risk. These findings should stimulate more awareness among health care providers to increase identification of gynecomastia and its causes in males.

Identifiants

pubmed: 36718997
pii: 7016774
doi: 10.1210/clinem/dgad048
pmc: PMC10271232
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e380-e387

Subventions

Organisme : NCI NIH HHS
ID : R01 CA236816
Pays : United States
Organisme : NIH HHS
ID : 1R01CA236816-01A1
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Med. 1984 Oct;77(4):633-8
pubmed: 6486139
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
Scand J Public Health. 2011 Jul;39(7 Suppl):42-5
pubmed: 21775350
Psychosom Med. 1962 Jul-Aug;24:379-89
pubmed: 13909166
Scand J Public Health. 2011 Jul;39(7 Suppl):12-6
pubmed: 21898916
Acad Radiol. 2018 May;25(5):626-635
pubmed: 29326049
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32710775
Andrology. 2019 Nov;7(6):778-793
pubmed: 31099174
Scand J Public Health. 2021 Jul;49(5):555-562
pubmed: 33280527
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Clin Endocrinol (Oxf). 1990 Jan;32(1):101-5
pubmed: 2331807
N Engl J Med. 2007 Sep 20;357(12):1229-37
pubmed: 17881754
J Clin Endocrinol Metab. 2023 Jun 16;108(7):e380-e387
pubmed: 36718997
J Clin Endocrinol Metab. 2022 May 17;107(6):1560-1568
pubmed: 35225342
Pediatr Res. 2002 Nov;52(5):682-6
pubmed: 12409513
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32754750
J Clin Endocrinol Metab. 2015 Oct;100(10):3752-9
pubmed: 26287961
Body Image. 2015 Sep;15:141-8
pubmed: 26408934
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Front Endocrinol (Lausanne). 2022 Dec 01;13:1048660
pubmed: 36531497
Indian J Endocrinol Metab. 2014 Mar;18(2):150-8
pubmed: 24741509
J Sex Med. 2009 Apr;6(4):989-1000
pubmed: 19175864

Auteurs

Cecilie S Uldbjerg (CS)

Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.

Youn-Hee Lim (YH)

Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen 1353, Denmark.
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Elvira V Bräuner (EV)

Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.

Anders Juul (A)

Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen 2100, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH